DE69600512D1 - Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur deren Herstellung - Google Patents

Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur deren Herstellung

Info

Publication number
DE69600512D1
DE69600512D1 DE69600512T DE69600512T DE69600512D1 DE 69600512 D1 DE69600512 D1 DE 69600512D1 DE 69600512 T DE69600512 T DE 69600512T DE 69600512 T DE69600512 T DE 69600512T DE 69600512 D1 DE69600512 D1 DE 69600512D1
Authority
DE
Germany
Prior art keywords
preparation
immunoassays
stabilized troponin
troponin
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69600512T
Other languages
English (en)
Other versions
DE69600512T2 (de
Inventor
Denis Robert Riochet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Pasteur Sanofi Diagnostics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics SA filed Critical Pasteur Sanofi Diagnostics SA
Publication of DE69600512D1 publication Critical patent/DE69600512D1/de
Application granted granted Critical
Publication of DE69600512T2 publication Critical patent/DE69600512T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69600512T 1995-05-16 1996-05-13 Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur deren Herstellung Expired - Lifetime DE69600512T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505788A FR2734267B1 (fr) 1995-05-16 1995-05-16 Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee

Publications (2)

Publication Number Publication Date
DE69600512D1 true DE69600512D1 (de) 1998-09-17
DE69600512T2 DE69600512T2 (de) 1999-04-15

Family

ID=9479025

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69600512T Expired - Lifetime DE69600512T2 (de) 1995-05-16 1996-05-13 Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur deren Herstellung

Country Status (9)

Country Link
US (2) US20010006683A1 (de)
EP (1) EP0743522B1 (de)
JP (1) JP3672672B2 (de)
AT (1) ATE169740T1 (de)
CA (1) CA2176655C (de)
DE (1) DE69600512T2 (de)
DK (1) DK0743522T3 (de)
ES (1) ES2122768T3 (de)
FR (1) FR2734267B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049994A1 (en) * 1996-06-25 1997-12-31 Oy Aboatech Ab Method and kit for the diagnosis of troponin i
US7285418B2 (en) 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE19647927A1 (de) * 1996-11-20 1998-05-28 Bayer Ag Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
WO1998054219A1 (en) * 1997-05-29 1998-12-03 Medical Analysis Systems Inc. Covalently coupled troponin complexes
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
EP1000140A1 (de) * 1997-06-13 2000-05-17 Medical Analysis Systems, Inc. (MAS) Stabilisierte herz-marker-zusammensetzungen
ATE463509T1 (de) * 2005-04-28 2010-04-15 Abbott Lab Stabilisierung von herz-troponin
CN103380377B (zh) * 2011-02-25 2016-01-27 美迪恩斯生命科技株式会社 心肌肌钙蛋白的测定方法
JP5759211B2 (ja) * 2011-03-11 2015-08-05 三洋化成工業株式会社 凍結乾燥方法
CN113125745B (zh) * 2019-12-31 2022-10-28 瑞博奥(广州)生物科技股份有限公司 一种心脏功能检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
DE4243648A1 (de) * 1992-12-23 1994-07-07 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Herzmuskelnekrosen mittels Antikörper gegen das N-terminale Troponin I-Peptid
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
JPH09503050A (ja) * 1993-05-17 1997-03-25 フォートロン バイオサイエンス インク． 心臓トロポニン▲ｉ▼のアッセイ
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays

Also Published As

Publication number Publication date
US20010006683A1 (en) 2001-07-05
FR2734267B1 (fr) 1997-08-01
EP0743522B1 (de) 1998-08-12
JP3672672B2 (ja) 2005-07-20
US20040033529A1 (en) 2004-02-19
JPH0921804A (ja) 1997-01-21
ATE169740T1 (de) 1998-08-15
DK0743522T3 (da) 1999-05-10
FR2734267A1 (fr) 1996-11-22
CA2176655A1 (en) 1996-11-17
EP0743522A1 (de) 1996-11-20
ES2122768T3 (es) 1998-12-16
DE69600512T2 (de) 1999-04-15
CA2176655C (en) 2002-01-29

Similar Documents

Publication Publication Date Title
AT384805B (de) Verfahren zur herstellung von neuen 1,2-diaminocyclobuten-3,4-dionen und deren salzen
DE69600512D1 (de) Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur deren Herstellung
AT383606B (de) Verfahren zur herstellung von neuen transparenten copolyamiden mischungen daraus, und deren verwendung zur herstellung von formkoerpern
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
DE3867684D1 (de) Kupferoxid-supraleiter mit gemischter wertigkeit und verfahren zu seiner herstellung.
ATE47138T1 (de) Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure).
DE59108892D1 (de) Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikörpern
ATE188976T1 (de) Kontinuierliches verfahren zur herstellung von resorbierbaren polyestern und deren verwendung
ATE148110T1 (de) Verfahren zur herstellung von metallkomplexen der n-beta-hydroxy-alkyl-tri-n-carboxyalkyl-1,4,7,1 - tetraazacyclododecan- und n-beta-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11 tetraazacyclotetradecan- derivate
ATE131149T1 (de) Verfahren zur herstellung von 5-(2,4- difluorphenyl)-salizylsäure.
AT388738B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
FI873125A0 (fi) Foerfarande foer framstaellning av 5,6-substituerade 2,4-kinazolindiaminer samt nya mellanprodukter.
ATE82747T1 (de) Verfahren zur herstellung von hydroxyalkylierungsmitteln, die erhaltenen mittel und deren verwendung.
AT388382B (de) Verfahren zur herstellung von wasserverduennbaren lackbindemitteln und deren verwendung
ATE117676T1 (de) Verfahren zur herstellung von molluskiziden 2,4,5-tribrompyrrol-3-carbonitrilen.
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
ATE127127T1 (de) Verfahren zur herstellung einer intramolekularen disulphid-brücke in polypeptiden.
ATE112264T1 (de) Verfahren zur herstellung von 2,6-di-t-butyl-4- merkaptophenol.
DE3882023D1 (de) Am aromatischen kern und an der seitenkette fluoratome enthaltende alkoxyaniline und verfahren zur herstellung von am aromatischen kern und an der seitenkette fluoratome enthaltenden alkoxyanilinen.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.
DE59107605D1 (de) Verfahren zur Herstellung von Titanchelaten
DE3577847D1 (de) Verfahren zur herstellung von cis-bicyclo(3.3.0)-octylidenderivaten.
ATE99683T1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen 2-pgiderivate, verfahren zur herstellung und deren verwendung.
DE3668626D1 (de) Verfahren zur herstellung von 7-alpha,acetylthiosteroiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIO-RAD PASTEUR, MARNES LA COQUETTE, FR